Acutaas Chemicals Limited — Financials & Forensics
Sector: Healthcare · NSE: ACUTAAS · BSE: 543349 · ISIN: INE00FF01025
28 Oct 2026
Add ACUTAAS to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY26 |
|---|---|---|---|---|
| Revenue from operations | ₹520 Cr | ₹617 Cr | ₹717 Cr | ₹1,339 Cr |
| EBITDA | ₹105 Cr | ₹123 Cr | ₹128 Cr | ₹480 Cr |
| EBITDA margin | 20.2% | 19.9% | 17.9% | 35.9% |
| Profit after tax | ₹72 Cr | ₹83 Cr | ₹49 Cr | ₹356 Cr |
Deeper analysis
Recent filings by Acutaas Chemicals Limited
-
Copy of Newspaper Publication
28 Oct 2026 · Regulatory Compliance
-
Analysts/Institutional Investor Meet/Con. Call Updates
27 Oct 2026 · General Update
-
Investor Presentation
27 Oct 2026 · Financial Results
-
Press Release
27 Oct 2026 · Financial Results
-
Outcome of Board Meeting
27 Oct 2026 · Financial Results
Never miss a filing again
About Acutaas Chemicals Limited on Indian Stock Alerts
Indian Stock Alerts tracks Acutaas Chemicals Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.